Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 111


Perspectives on Inflammatory Breast Cancer (IBC) Research, Clinical Management and Community Engagement from the Duke IBC Consortium.

Devi GR, Hough H, Barrett N, Cristofanilli M, Overmoyer B, Spector N, Ueno NT, Woodward W, Kirkpatrick J, Vincent B, Williams KP, Finley C, Duff B, Worthy V, McCall S, Hollister BA, Palmer G, Force J, Westbrook K, Fayanju O, Suneja G, Dent SF, Hwang ES, Patierno SR, Marcom PK.

J Cancer. 2019 Jun 4;10(15):3344-3351. doi: 10.7150/jca.31176. eCollection 2019. Review.


Alternative RNA Splicing as a Potential Major Source of Untapped Molecular Targets in Precision Oncology and Cancer Disparities.

Robinson TJ, Freedman JA, Al Abo M, Deveaux AE, LaCroix B, Patierno BM, George DJ, Patierno SR.

Clin Cancer Res. 2019 May 15;25(10):2963-2968. doi: 10.1158/1078-0432.CCR-18-2445. Epub 2019 Feb 12.


Single-nucleotide polymorphisms of stemness genes predicted to regulate RNA splicing, microRNA and oncogenic signaling are associated with prostate cancer survival.

Freedman JA, Wang Y, Li X, Liu H, Moorman PG, George DJ, Lee NH, Hyslop T, Wei Q, Patierno SR.

Carcinogenesis. 2018 Jul 3;39(7):879-888. doi: 10.1093/carcin/bgy062.


Corrigendum: Alternative splicing promotes tumour aggressiveness and drug resistance in African American prostate cancer.

Wang BD, Ceniccola K, Hwang S, Andrawis R, Horvath A, Freedman JA, Olender J, Knapp S, Ching T, Garmire L, Patel V, Garcia-Blanco MA, Patierno SR, Lee NH.

Nat Commun. 2017 Sep 27;8:16161. doi: 10.1038/ncomms16161.


Alternative splicing promotes tumour aggressiveness and drug resistance in African American prostate cancer.

Wang BD, Ceniccola K, Hwang S, Andrawis R, Horvath A, Freedman JA, Olender J, Knapp S, Ching T, Garmire L, Patel V, Garcia-Blanco MA, Patierno SR, Lee NH.

Nat Commun. 2017 Jun 30;8:15921. doi: 10.1038/ncomms15921. Erratum in: Nat Commun. 2017 Sep 27;8:16161.


Associations between RNA splicing regulatory variants of stemness-related genes and racial disparities in susceptibility to prostate cancer.

Wang Y, Freedman JA, Liu H, Moorman PG, Hyslop T, George DJ, Lee NH, Patierno SR, Wei Q.

Int J Cancer. 2017 Aug 15;141(4):731-743. doi: 10.1002/ijc.30787. Epub 2017 Jun 1.


Bisphenol A activates EGFR and ERK promoting proliferation, tumor spheroid formation and resistance to EGFR pathway inhibition in estrogen receptor-negative inflammatory breast cancer cells.

Sauer SJ, Tarpley M, Shah I, Save AV, Lyerly HK, Patierno SR, Williams KP, Devi GR.

Carcinogenesis. 2017 Mar 1;38(3):252-260. doi: 10.1093/carcin/bgx003.


Relation of comorbidities and patient navigation with the time to diagnostic resolution after abnormal cancer screening.

Whitley EM, Raich PC, Dudley DJ, Freund KM, Paskett ED, Patierno SR, Simon M, Warren-Mears V, Snyder FR; Patient Navigation Research Program Investigators.

Cancer. 2017 Jan 1;123(2):312-318. doi: 10.1002/cncr.30316. Epub 2016 Sep 20.


Snail promotes resistance to enzalutamide through regulation of androgen receptor activity in prostate cancer.

Ware KE, Somarelli JA, Schaeffer D, Li J, Zhang T, Park S, Patierno SR, Freedman J, Foo WC, Garcia-Blanco MA, Armstrong AJ.

Oncotarget. 2016 Aug 2;7(31):50507-50521. doi: 10.18632/oncotarget.10476.


Impact of Patient Navigation Interventions on Timely Diagnostic Follow Up for Abnormal Cervical Screening.

Paskett ED, Dudley D, Young GS, Bernardo BM, Wells KJ, Calhoun EA, Fiscella K, Patierno SR, Warren-Mears V, Battaglia TA; PNRP Investigators.

J Womens Health (Larchmt). 2016 Jan;25(1):15-21. doi: 10.1089/jwh.2014.5094. Epub 2015 Dec 1.


Barriers to health care contribute to delays in follow-up among women with abnormal cancer screening: Data from the Patient Navigation Research Program.

Ramachandran A, Snyder FR, Katz ML, Darnell JS, Dudley DJ, Patierno SR, Sanders MR, Valverde PA, Simon MA, Warren-Mears V, Battaglia TA; Patient Navigation Research Program Investigators.

Cancer. 2015 Nov 15;121(22):4016-24. doi: 10.1002/cncr.29607. Epub 2015 Aug 19.


Impact of patient navigation in eliminating economic disparities in cancer care.

Rodday AM, Parsons SK, Snyder F, Simon MA, Llanos AA, Warren-Mears V, Dudley D, Lee JH, Patierno SR, Markossian TW, Sanders M, Whitley EM, Freund KM.

Cancer. 2015 Nov 15;121(22):4025-34. doi: 10.1002/cncr.29612. Epub 2015 Sep 8.


Identification and Functional Validation of Reciprocal microRNA-mRNA Pairings in African American Prostate Cancer Disparities.

Wang BD, Ceniccola K, Yang Q, Andrawis R, Patel V, Ji Y, Rhim J, Olender J, Popratiloff A, Latham P, Lai Y, Patierno SR, Lee NH.

Clin Cancer Res. 2015 Nov 1;21(21):4970-84. doi: 10.1158/1078-0432.CCR-14-1566. Epub 2015 Jun 18.


Can patient navigation improve receipt of recommended breast cancer care? Evidence from the National Patient Navigation Research Program.

Ko NY, Darnell JS, Calhoun E, Freund KM, Wells KJ, Shapiro CL, Dudley DJ, Patierno SR, Fiscella K, Raich P, Battaglia TA.

J Clin Oncol. 2014 Sep 1;32(25):2758-64. doi: 10.1200/JCO.2013.53.6037. Epub 2014 Jul 28.


Impact of patient navigation on timely cancer care: the Patient Navigation Research Program.

Freund KM, Battaglia TA, Calhoun E, Darnell JS, Dudley DJ, Fiscella K, Hare ML, LaVerda N, Lee JH, Levine P, Murray DM, Patierno SR, Raich PC, Roetzheim RG, Simon M, Snyder FR, Warren-Mears V, Whitley EM, Winters P, Young GS, Paskett ED; Writing Group of the Patient Navigation Research Program.

J Natl Cancer Inst. 2014 Jun 17;106(6):dju115. doi: 10.1093/jnci/dju115. Print 2014 Jun.


Barriers reported among patients with breast and cervical abnormalities in the patient navigation research program: impact on timely care.

Katz ML, Young GS, Reiter PL, Battaglia TA, Wells KJ, Sanders M, Simon M, Dudley DJ, Patierno SR, Paskett ED.

Womens Health Issues. 2014 Jan-Feb;24(1):e155-62. doi: 10.1016/j.whi.2013.10.010.


Costs and outcomes evaluation of patient navigation after abnormal cancer screening: evidence from the Patient Navigation Research Program.

Bensink ME, Ramsey SD, Battaglia T, Fiscella K, Hurd TC, McKoy JM, Patierno SR, Raich PC, Seiber EE, Warren-Mears V, Whitley E, Paskett ED, Mandelblatt S; Patient Navigation Research Program.

Cancer. 2014 Feb 15;120(4):570-8. doi: 10.1002/cncr.28438. Epub 2013 Oct 25.


A bioenergetic profile of non-transformed fibroblasts uncovers a link between death-resistance and enhanced spare respiratory capacity.

Nickens KP, Wikstrom JD, Shirihai OS, Patierno SR, Ceryak S.

Mitochondrion. 2013 Nov;13(6):662-7. doi: 10.1016/j.mito.2013.09.005. Epub 2013 Sep 27.


Androgen receptor-target genes in african american prostate cancer disparities.

Wang BD, Yang Q, Ceniccola K, Bianco F, Andrawis R, Jarrett T, Frazier H, Patierno SR, Lee NH.

Prostate Cancer. 2013;2013:763569. doi: 10.1155/2013/763569. Epub 2013 Jan 10.


Patient navigation significantly reduces delays in breast cancer diagnosis in the District of Columbia.

Hoffman HJ, LaVerda NL, Young HA, Levine PH, Alexander LM, Brem R, Caicedo L, Eng-Wong J, Frederick W, Funderburk W, Huerta E, Swain S, Patierno SR.

Cancer Epidemiol Biomarkers Prev. 2012 Oct;21(10):1655-63. doi: 10.1158/1055-9965.EPI-12-0479.


Protein tyrosine phosphatase (PTP) inhibition enhances chromosomal stability after genotoxic stress: decreased chromosomal instability (CIN) at the expense of enhanced genomic instability (GIN)?

Kost GC, Patierno SR, Wise SS, Holmes AL, Wise JP Sr, Ceryak S.

Mutat Res. 2012 Jul 1;735(1-2):51-5. doi: 10.1016/j.mrfmmm.2012.05.001. Epub 2012 May 11.


Exposure to particulate hexavalent chromium exacerbates allergic asthma pathology.

Schneider BC, Constant SL, Patierno SR, Jurjus RA, Ceryak SM.

Toxicol Appl Pharmacol. 2012 Feb 15;259(1):38-44. doi: 10.1016/j.taap.2011.12.001. Epub 2011 Dec 9.


Acquisition of mitochondrial dysregulation and resistance to mitochondrial-mediated apoptosis after genotoxic insult in normal human fibroblasts: a possible model for early stage carcinogenesis.

Nickens KP, Han Y, Shandilya H, Larrimore A, Gerard GF, Kaldjian E, Patierno SR, Ceryak S.

Biochim Biophys Acta. 2012 Feb;1823(2):264-72. doi: 10.1016/j.bbamcr.2011.10.005. Epub 2011 Oct 25.


Having health insurance does not eliminate race/ethnicity-associated delays in breast cancer diagnosis in the District of Columbia.

Hoffman HJ, LaVerda NL, Levine PH, Young HA, Alexander LM, Patierno SR; District of Columbia Citywide Patient Navigator Research Program Research Group.

Cancer. 2011 Aug 15;117(16):3824-32. doi: 10.1002/cncr.25970. Epub 2011 Feb 24.


Structural and reliability analysis of a patient satisfaction with cancer-related care measure: a multisite patient navigation research program study.

Jean-Pierre P, Fiscella K, Freund KM, Clark J, Darnell J, Holden A, Post D, Patierno SR, Winters PC; Patient Navigation Research Program Group.

Cancer. 2011 Feb 15;117(4):854-61. doi: 10.1002/cncr.25501. Epub 2010 Oct 4.


Identification of differentially methylated genes in normal prostate tissues from African American and Caucasian men.

Kwabi-Addo B, Wang S, Chung W, Jelinek J, Patierno SR, Wang BD, Andrawis R, Lee NH, Apprey V, Issa JP, Ittmann M.

Clin Cancer Res. 2010 Jul 15;16(14):3539-47. doi: 10.1158/1078-0432.CCR-09-3342. Epub 2010 Jul 6.


Prostate apoptosis response protein 4 sensitizes human colon cancer cells to chemotherapeutic 5-FU through mediation of an NF kappaB and microRNA network.

Wang BD, Kline CL, Pastor DM, Olson TL, Frank B, Luu T, Sharma AK, Robertson G, Weirauch MT, Patierno SR, Stuart JM, Irby RB, Lee NH.

Mol Cancer. 2010 Apr 30;9:98. doi: 10.1186/1476-4598-9-98.


Chromium genotoxicity: A double-edged sword.

Nickens KP, Patierno SR, Ceryak S.

Chem Biol Interact. 2010 Nov 5;188(2):276-88. doi: 10.1016/j.cbi.2010.04.018. Epub 2010 Apr 27. Review.


Polo-like kinase 1 enhances survival and mutagenesis after genotoxic stress in normal cells through cell cycle checkpoint bypass.

Chun G, Bae D, Nickens K, O'Brien TJ, Patierno SR, Ceryak S.

Carcinogenesis. 2010 May;31(5):785-93. doi: 10.1093/carcin/bgq014. Epub 2010 Jan 20.


Lung inflammation, injury, and proliferative response after repetitive particulate hexavalent chromium exposure.

Beaver LM, Stemmy EJ, Schwartz AM, Damsker JM, Constant SL, Ceryak SM, Patierno SR.

Environ Health Perspect. 2009 Dec;117(12):1896-902. doi: 10.1289/ehp.0900715. Epub 2009 Aug 19.


Transscaphoid perilunate dislocation.

Kloss BT, Patierno SR, Sullivan AM.

Int J Emerg Med. 2010 Sep 4;3(4):501-2. doi: 10.1007/s12245-010-0212-x. No abstract available.


Vomiting in a 22-day-old firstborn male.

Kloss BT, Patierno SR.

Int J Emerg Med. 2010 Jul 13;3(4):487-8. doi: 10.1007/s12245-010-0181-0. No abstract available.


DNA polymerase zeta is essential for hexavalent chromium-induced mutagenesis.

O'Brien TJ, Witcher P, Brooks B, Patierno SR.

Mutat Res. 2009 Apr 26;663(1-2):77-83. doi: 10.1016/j.mrfmmm.2009.01.012. Epub 2009 Feb 6.


AKT1 mediates bypass of the G1/S checkpoint after genotoxic stress in normal human cells.

Lal MA, Bae D, Camilli TC, Patierno SR, Ceryak S.

Cell Cycle. 2009 May 15;8(10):1589-602. Epub 2009 May 25.


Lung injury, inflammation and Akt signaling following inhalation of particulate hexavalent chromium.

Beaver LM, Stemmy EJ, Constant SL, Schwartz A, Little LG, Gigley JP, Chun G, Sugden KD, Ceryak SM, Patierno SR.

Toxicol Appl Pharmacol. 2009 Feb 15;235(1):47-56. doi: 10.1016/j.taap.2008.11.018. Epub 2008 Dec 9.


Bypass of hexavalent chromium-induced growth arrest by a protein tyrosine phosphatase inhibitor: enhanced survival and mutagenesis.

Bae D, Camilli TC, Chun G, Lal M, Wright K, O'Brien TJ, Patierno SR, Ceryak S.

Mutat Res. 2009 Jan 15;660(1-2):40-6. doi: 10.1016/j.mrfmmm.2008.10.006. Epub 2008 Oct 21.


Excision repair is required for genotoxin-induced mutagenesis in mammalian cells.

Brooks B, O'Brien TJ, Ceryak S, Wise JP Sr, Wise SS, Wise JP Jr, Defabo E, Patierno SR.

Carcinogenesis. 2008 May;29(5):1064-9. doi: 10.1093/carcin/bgn058. Epub 2008 Mar 10.


Incision of trivalent chromium [Cr(III)]-induced DNA damage by Bacillus caldotenax UvrABC endonuclease.

O'Brien TJ, Jiang G, Chun G, Mandel HG, Westphal CS, Kahen K, Montaser A, States JC, Patierno SR.

Mutat Res. 2006 Nov 7;610(1-2):85-92. Epub 2006 Aug 4.


Resistance to apoptosis, increased growth potential, and altered gene expression in cells that survived genotoxic hexavalent chromium [Cr(VI)] exposure.

Pritchard DE, Ceryak S, Ramsey KE, O'Brien TJ, Ha L, Fornsaglio JL, Stephan DA, Patierno SR.

Mol Cell Biochem. 2005 Nov;279(1-2):169-81.


Differential impact of ionic and coordinate covalent chromium (Cr)-DNA binding on DNA replication.

Fornsaglio JL, O'Brien TJ, Patierno SR.

Mol Cell Biochem. 2005 Nov;279(1-2):149-55.


Nucleotide excision repair functions in the removal of chromium-induced DNA damage in mammalian cells.

O'Brien TJ, Brooks BR, Patierno SR.

Mol Cell Biochem. 2005 Nov;279(1-2):85-95.


Hypoxia impedes the formation of chromium DNA-adducts in a cell-free system.

O'Brien TJ, Mandel HG, Sugden KD, Komarov AM, Patierno SR.

Biochem Pharmacol. 2005 Dec 5;70(12):1814-22. Epub 2005 Oct 19.


Angiotropism of human prostate cancer cells: implications for extravascular migratory metastasis.

Lugassy C, Vernon SE, Warner JW, Le CQ, Manyak M, Patierno SR, Barnhill RL.

BJU Int. 2005 May;95(7):1099-103.


Breast cancer aggressiveness and racial disparity.

Henson DE, Patierno SR.

Breast Cancer Res Treat. 2004 Oct;87(3):291-6. No abstract available.


Generation of S phase-dependent DNA double-strand breaks by Cr(VI) exposure: involvement of ATM in Cr(VI) induction of gamma-H2AX.

Ha L, Ceryak S, Patierno SR.

Carcinogenesis. 2004 Nov;25(11):2265-74. Epub 2004 Jul 29.


Uteroglobin: a potential novel tumor suppressor and molecular therapeutic for prostate cancer.

Patierno SR, Manyak MJ, Fernandez PM, Baker A, Weeraratna AT, Chou DS, Szlyk G, Geib KS, Walsh C, Patteras J.

Clin Prostate Cancer. 2002 Sep;1(2):118-24. Review.


Pericyte-like location of GFP-tagged melanoma cells: ex vivo and in vivo studies of extravascular migratory metastasis.

Lugassy C, Kleinman HK, Engbring JA, Welch DR, Harms JF, Rufner R, Ghanem G, Patierno SR, Barnhill RL.

Am J Pathol. 2004 Apr;164(4):1191-8.


Tissue factor and fibrin in tumor angiogenesis.

Fernandez PM, Patierno SR, Rickles FR.

Semin Thromb Hemost. 2004 Feb;30(1):31-44. Review.


Mechanisms of chromium-induced suppression of RNA synthesis in cellular and cell-free systems: relationship to RNA polymerase arrest.

Xu J, Manning FC, O'Brien TJ, Ceryak S, Patierno SR.

Mol Cell Biochem. 2004 Jan;255(1-2):151-60.


Supplemental Content

Loading ...
Support Center